BL-8040
Drug timelines are a Plus or Pro feature.
11 regulatory and trial events tracked for BL-8040, covering 2015-07-31 to 2025-02-19. Get the full timeline:
Most recent: Clinical Trial Update: Pembrolizumab and CXCR4 Antagonist BL-8040 in Treating Patients With Metastatic Pancreatic Cancer [Phase 2]